Skip to main content
. 2014 Oct 30;10(10):e1003878. doi: 10.1371/journal.pcbi.1003878

Table 1. Model parameters.

Parameter Realistic Value Description Reference
n 1–8 Number of epitopes recognized during first 100 days [11], [13], [30], [31]
m 2–10 Number of sites per epitope important for recognition [11], [13], [30], [31]
Inline graphic 1 Inline graphic Rate at which activated target cells transition out of the highly infectable phase [46], [68]
Inline graphic Inline graphic cells Activated target cell level [47], [69], [70]
Inline graphic 1 Inline graphic Virus-induced infected cell death rate [55]
Inline graphic 4 Inline graphic CTL-induced infected cell death rate [47], [69], [70]
β Inline graphic Basic efficiency of target cell infection [47], [69], [70]
s Inline graphic Intrinsic mutation cost [10], [21], [22], [27][29]
α Inline graphic Reduction of CTL recognition [27][29]
Inline graphic Inline graphic Fractional reduction in intrinsic replication rate
Inline graphic Inline graphic Fractional reduction of CTL recognition
Inline graphic Inline graphic CTL killing efficiency. Gives Inline graphic CTLs in chronic infection [45]
Inline graphic Inline graphic cells Initial population of CTLs [69]
c 1 Inline graphic Maximum growth rate of effector cells [69]
Inline graphic 0.1 Inline graphic Death rate of effector cells [47], [69], [70]
Inline graphic Inline graphic cells Number of recognized infected cells for half maximal proliferation of CTL (inverse avidity). Gives an infected cell level of Inline graphic in chronic infection [44]

Model parameters for the model of escape from multiple CTL shown in Figure 1.